TY  - JOUR
AU  - Sánchez-Paulete, Alfonso R
AU  - Cueto, Francisco J.
AU  - Martínez-López, María
AU  - Labiano, Sara
AU  - Morales-Kastresana, Aizea
AU  - Rodríguez-Ruiz, María E
AU  - Jure-Kunkel, Maria
AU  - Azpilikueta, Arantza
AU  - Aznar, M Angela
AU  - Quetglas, José I
AU  - Sancho, David
AU  - Melero, Ignacio
PY  - 2016
DO  - 10.1158/2159-8290.CD-15-0510
SN  - 2159-8274
UR  - http://hdl.handle.net/20.500.12105/9721
AB  - UNLABELLED: Weak and ineffective antitumor cytotoxic T lymphocyte (CTL) responses can be rescued by immunomodulatory mAbs targeting PD-1 or CD137. Using Batf3(-/-) mice, which are defective for cross-presentation of cell-associated antigens, we show...
LA  - eng
PB  - American Association for Cancer Research (AACR)
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - Basic-Leucine Zipper Transcription Factors
KW  - Cell Line, Tumor
KW  - Dendritic Cells
KW  - Humans
KW  - Immunotherapy
KW  - Lymphocyte Activation
KW  - Melanoma, Experimental
KW  - Mice
KW  - Mice, Transgenic
KW  - Programmed Cell Death 1 Receptor
KW  - Repressor Proteins
KW  - Tumor Necrosis Factor Receptor Superfamily, Member 9
TI  - Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
TY  - journal article
ER  -